Article
COVID-19: Impact on Canada’s pharmaceutical and retail pharmacy industry
A view of the unique challenges and opportunities
The coronavirus pandemic has affected Canada’s pharmaceutical and retail pharmacy industry across four main areas: product sourcing and procurement, product launch and distribution, acquisition and access, and treatment and care management. Based on challenges in these areas, this report offers a perspective on potential solutions and considerations.
Topics covered in this paper include:
- How COVID-19 has affected the Canadian life sciences industry
- Thinking through the unique challenges of COVID-19
- Top challenges facing the industry
- Opportunities to address key challenges and prepare for the future
- Key considerations for successfully navigating through unprecedented times
Key contacts:
Shanil Ebrahim
Life Sciences & Health Care AI Leader
Rob Lanoue
Partner, Customer Insights Leader